Novavax’s long-awaited COVID-19 vaccine authorizations …

Novavax, like other companies, is working on an Omicron-tailored version of its vaccine. On Monday it also launched a booster dose study with participants from the North American trial who will receive a third dose of either Novavax or another vaccine. Vaccine-poor countries may eagerly take Novavax’s product, given its ease of use.

https://www.science.org/content/article/novavax-s-long-awaited-covid-19-vaccine-authorizations-offer-alternative-mrna